Anna Faaborg

Anna joined 23andMe in 2013 and leads a team of project managers responsible for execution of longitudinal research studies. These studies actively recruit participants with specific conditions, such as lupus, with the goals of uncovering the genetic factors contributing to disease risk, severity, and response to treatments. Previously, she was a project manager at Genentech, where she managed execution of biomarker plans for oncology clinical trials. Anna received a Master’s degree in Genetics and Development from Columbia University.